Rocket Lab’s outlook disappoints, but SpaceX-style growth is still ahead: analyst - MarketWatch
1. Rocket Lab shares fell despite strong long-term prospects. 2. KeyBanc lowered the price target to $28 but maintained overweight rating. 3. Neutron rocket launch pushed to second half of 2025, affecting investor sentiment. 4. Company introduced new Flatellite technology for large constellations. 5. Short-term growth is expected to resume in Q2 2024.